nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

28.06.2016 | Image of the Month

99mTc-DPD-scintigraphy with intense uptake in fat tissue caused by AL-amyloidosis

verfasst von: M. Zoller, G. Hajnos, R. Burkhard, S. Kneifel

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Excerpt

A dual–phase Technetium-99m 3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) bone scintigraphy was performed to assess inflammatory joint involvement due to suspected rheumatological disease in a 44-year-old female, complaining of progredient musculo-skeletal pain syndrome, stiffness, and a tightness of the skin. …

Hutt D, Quigley AM, Page J, et al. Utility and limitations of 3,3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging. 2014;15(11):1289–98.CrossRefPubMed

Perugini E, Guidalotti PL, Salvi F, et al. Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Disphono-1,2-Propanodicarboxylic Acid Scintigraphy. J Am Coll Cardiol. 2005;46(6):1076–84.CrossRefPubMed

Rapezzi C, Quarta CC, Guidalotti PL, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2011;38(3):470–8.CrossRefPubMed

Titel: 99mTc-DPD-scintigraphy with intense uptake in fat tissue caused by AL-amyloidosis
verfasst von: M. Zoller
G. Hajnos
R. Burkhard
S. Kneifel
Publikationsdatum: 28.06.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3446-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2016

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism

ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer

Guidelines to PET measurements of the target occupancy in the brain for drug development

Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand

Striatal hypometabolism in premanifest and manifest Huntington’s disease patients

Feasibility and acceptance of simultaneous amyloid PET/MRI